Ropes & Gray represented MicroPort Scientific Corp, one of China's leading medical device manufacturers, in its recent HKD 1.77 billion (US$228 million) global offering and listing on the Main Board of the Hong Kong Stock Exchange.
MicroPort is China's largest supplier of coronary stents. The company plans to use proceeds of the IPO to develop new products, expand its production facilities and build its sales network.
Ropes & Gray has handled high-profile transactions and financings in Asia since opening a Hong Kong office in 2008. Earlier this year, the firm was recognized by Asian Legal Business for its role in China's "M&A Deal of the Year" for 2009; Ropes & Gray represented the majority exchangeable bondholder in connection with Jiangsu Zhongneng's debt restructuring and subsequent consolidation with GCL-Poly Energy Holdings Ltd.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.